| 000 | 01811 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517223513.0 | ||
| 264 | 0 | _c20191223 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdy167 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHutchings, M | |
| 245 | 0 | 0 |
_aESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patients. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _c08 2018 |
||
| 300 |
_a1687-1700 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aConsensus Development Conferences as Topic |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma _xdiagnosis |
| 650 | 0 | 4 |
_aMedical Oncology _xmethods |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnosis |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aRadiotherapy, Adjuvant _xmethods |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSocieties, Medical _xstandards |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLadetto, M | |
| 700 | 1 | _aBuske, C | |
| 700 | 1 | _ade Nully Brown, P | |
| 700 | 1 | _aFerreri, A J M | |
| 700 | 1 | _aPfreundschuh, M | |
| 700 | 1 | _aSchmitz, N | |
| 700 | 1 | _aBalari, A Sureda | |
| 700 | 1 | _avan Imhoff, G | |
| 700 | 1 | _aWalewski, J | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 29 _gno. 8 _gp. 1687-1700 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdy167 _zAvailable from publisher's website |
| 999 |
_c28551530 _d28551530 |
||